Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 33 recruiting now early-phase tilt

Acute Kidney Injury: early-phase trial registry

33 of 75 indexed Acute Kidney Injury trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #178 of 28,707 conditions by registered trial count.

75 US clinical trials · 33 currently recruiting · #178 of 28,707 conditions by registered trial count

Acute Kidney Injury: 75 US clinical trials tracked, 33 recruiting.

Acute Kidney Injury is the subject of 75 registered US clinical trials on ClinicalTrials.gov, 33 of them currently open to new participants. 6 are in Phase 3-4 (later-stage) and 22 in Phase 1-2 (earlier-stage). The most active sponsor is Brigham and Women's Hospital, running 3 of these trials.

Enrollment posture brief

Registry condition acute-kidney-injury

OPEN 33 | RECR 44% | LATE 6 | EARLY 22 | RANK #178 | SPON 3

Nearest open-share peer: Acute Lymphoblastic Leukemia (44% recruiting · 132 trials)

Acute Kidney Injury (this)44%Infertility33.3%Age-related Macular Degenera26.7%Tobacco Use Disorder25.3%Pulmonary Disease, Chronic O9.3%
Open-enrollment share among volume-matched conditions near Acute Kidney Injury

Acute Kidney Injury lists 33 open slots (44% of 75 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Acute Kidney Injury on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Acute Kidney Injury is recruiting above its size-band peers.

    33 of 75 indexed trials (44%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. Sponsorship of Acute Kidney Injury trials is spread across many organizations.

    Brigham and Women's Hospital accounts for 3 of 75 trials (4%). 58 distinct sponsors appear on at least one study for this condition label.

  3. Typical Acute Kidney Injury enrolment sits around 148 participants.

    Median target enrolment is 148 among the 75 trials that report a genuine target (sentinel values excluded). 28 of those (37.3%) plan for fewer than 100 participants.

  4. Acute Kidney Injury splits between interventional and observational designs.

    46 interventional and 29 observational studies make up this index (61.3% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 16Phase 216Phase 34Phase 42

Open and recent trials

75 total, page 1 of 2

RECRUITING 2,500 participants

Physiologic Signals and Signatures With the Accuryn Monitoring System - The Accuryn Registry

Potrero Medical

NCT04669548

RECRUITING NA 2,145 participants

A Patient-centered Trial of a Process-of-care Intervention in Hospitalized AKI Patients: the COPE-AKI Trial

University of Pittsburgh

NCT05805709

RECRUITING 2,000 participants

KIDney Injury in Times of COVID-19 (KIDCOV)

University of California, San Francisco

NCT04705766

RECRUITING NA 1,100 participants

Optimizing Pulsatility During Cardiopulmonary Bypass to Reduce Acute Kidney Injury

University of Colorado, Denver

NCT06349577

RECRUITING NA 842 participants

CTSN Embolic Protection Trial

Icahn School of Medicine at Mount Sinai

NCT06027788

RECRUITING 800 participants

Combining Biomarkers and Electronic Risk Scores to Predict AKI in Hospitalized Patients

University of Chicago

NCT05988658

RECRUITING Phase 4 750 participants

A Pragmatic Clinical Trial Comparing the Risk of Acute Kidney Injury During Treatment With Vancomycin and Piperacillin-Tazobactam vs. Vancomycin and Cefepime in Hospitalized Patients

University of Pennsylvania

NCT06954129

RECRUITING 450 participants

Novel Treatments in Improving Renal Outcomes in Light Chain Cast Nephropathy

Brigham and Women's Hospital

NCT06483139

RECRUITING Phase 2 400 participants

Post-Cardiac Surgery Acute Kidney Injury Prevention by Administration of Proton Pump Inhibitor (P2 Trial)

The University of Texas Health Science Center, Houston

NCT06706258

RECRUITING Phase 2 304 participants

NAD+ Augmentation in Cardiac Surgery Associated Myocardial Injury Trial

Kaiser Permanente

NCT04750616

RECRUITING Phase 3 300 participants

Melatonin for Prevention of Kidney Injury

Rutgers, The State University of New Jersey

NCT05084196

RECRUITING Phase 4 300 participants

Low Dose Vasopressin vs Phenylephrine in Cardiac Surgery

Thomas Jefferson University

NCT04602767

RECRUITING 300 participants

QUELIMMUNE (SCD-PED) PediAtric SurVeillance REgistry

SeaStar Medical

NCT06517810

RECRUITING 260 participants

Kidney Function in People With Cystic Fibrosis in the Era of HEMT

University of Virginia

NCT06595420

RECRUITING Phase 2 240 participants

Remote Ischemic Preconditioning for Renal and Cardiac Protection in Congestive Heart Failure (RICH) Trial

VA Office of Research and Development

NCT04982419

RECRUITING NA 200 participants

Neutrophil and Monocyte Deactivation Via the SeLective CytopheretIc Device - A Randomized Clinical Trial in Acute Kidney Injury

SeaStar Medical

NCT05758077

RECRUITING Phase 2 130 participants

Sodium-Glucose Cotransporter-2 Inhibitor for Patients With Acute Cardiorenal Syndrome

Yale University

NCT07273838

RECRUITING NA 124 participants

Groundbreaking Renal Assist Device Intervening to ENhance cardioThoracic Surgery Outcomes

3ive Labs

NCT07017933

RECRUITING Phase 2 124 participants

A Study to Investigate the Efficacy, Safety, and Tolerability of AZD4144in Participants With Sepsis-associated Acute Kidney Injury.

AstraZeneca

NCT07215702

RECRUITING 100 participants

Acute Normovolemic Hemodilution on Urine Neutrophil Gelatinase-associated Lipocalin Levels

University of Maryland, Baltimore

NCT05349292

RECRUITING Phase 2 100 participants

Comparison of Early Proton Pump Inhibitor Initiation Versus Usual Care on Acute Kidney Injury in Hemorrhagic Shock Patients

The University of Texas Health Science Center, Houston

NCT06531642

RECRUITING 100 participants

Cystatin and Early AKI Detection Contrast Induced Acute Kidney Injury

BayCare Health System

NCT07197957

RECRUITING Phase 2 75 participants

Droxidopa to Increase Mean Arterial Pressure in Decompensated Cirrhosis Patients With Acute Kidney Injury

Giuseppe Cullaro, MD

NCT06937307

RECRUITING NA 70 participants

Nafamostat Efficacy in Phase 3 Registrational CRRT Study

Talphera

NCT06150742

RECRUITING Phase 1 70 participants

Allogeneic HB-adMSCs vs Placebo for the Treatment of Acute Kidney Injury

Hope Biosciences

NCT06654193

RECRUITING 66 participants

Optimizing Pulsatility During Cardiopulmonary Bypass

University of Colorado, Denver

NCT05344573

RECRUITING Phase 3 50 participants

SAfety of Regional Citrate Anticoagulation (SARCA Study)

Fresenius Medical Care North America

NCT05339139

RECRUITING NA 50 participants

Initial Resuscitation for Acute Kidney Injury in Cirrhosis

Massachusetts General Hospital

NCT06525623

RECRUITING NA 50 participants

The Biosonographic Index

University of Alabama at Birmingham

NCT04144894

RECRUITING Phase 3 32 participants

Ultra-Low Contrast Angiography in AKI

Tulane University

NCT05906758

RECRUITING Phase 1 30 participants

Theophylline Prophylaxis During Hypothermia to Limit Neonatal Nephron Damage

Medical College of Wisconsin

NCT05853601

RECRUITING NA 25 participants

A Study of Facilitators and Barriers to Improve Acute Kidney Injury in Children Through Mobile Health Intervention

Duke University

NCT04403633

RECRUITING NA 20 participants

Effects of Creatine Supplementation on Cognitive Measures and Markers of Acute Kidney Injury After Exercise in the Heat

University of Northern Iowa

NCT07472426

ACTIVE NOT RECRUITING 800 participants

Establishment of ProNephro AKI (NGAL) Cut Off Value for Risk Assessment of Moderate to Severe Acute Kidney Injury in Adults

BioPorto Diagnostics

NCT06652100

ACTIVE NOT RECRUITING 450 participants

Clinical Validation of the RENISCHEM L-FABP POC Assay

Hikari Dx

NCT04864847

ACTIVE NOT RECRUITING Phase 2 320 participants

Deferoxamine for the Prevention of Cardiac Surgery-Associated Acute Kidney Injury

Brigham and Women's Hospital

NCT04633889

ACTIVE NOT RECRUITING 240 participants

Network Analysis of Urinary Molecular Signature Complements Clinical Data to Predict Postoperative Acute Kidney Injury

University of Florida

NCT02114138

ACTIVE NOT RECRUITING NA 180 participants

An Early Real-Time Electronic Health Record Risk Algorithm for the Prevention and Treatment of Acute Kidney Injury

University of Chicago

NCT03590028

ACTIVE NOT RECRUITING Phase 2 150 participants

A Study of Auxora in Patients With AKI and Injurious Lung "Crosstalk"

CalciMedica

NCT06374797

ACTIVE NOT RECRUITING 62 participants

Acute Kidney Injury Genomics and Biomarkers in TAVR Study

University of Texas Southwestern Medical Center

NCT02791880

ACTIVE NOT RECRUITING 36 participants

Prospective, Multi-center, Single-arm, Observational Study. US FDA 522 Pediatric Post Market Surveillance Study.

Medtronic - MITG

NCT04608149

ACTIVE NOT RECRUITING 10 participants

Critical Illness Myopathy and Trajectory of Recovery in AKI Requiring CRRT

University of Iowa

NCT05287204

COMPLETED 104,000 participants

Effect of Volume and Type of Fluid on Postoperative Incidence of Respiratory Complications and Outcome (CRC-Study)

Massachusetts General Hospital

NCT02105298

COMPLETED NA 14,000 participants

Saline Against Lactated Ringers or Plasmalyte in the Emergency Department

Vanderbilt University

NCT02614040

COMPLETED NA 12,108 participants

Pediatric Acute Kidney Injury (AKI) Retrospective, Real-Time and Repository Research

Vanderbilt University Medical Center

NCT02660931

COMPLETED NA 10,421 participants

Isotonic Solutions and Major Adverse Renal Events Trial in the Non-Medical Intensive Care Unit (SMART-SURG)

Vanderbilt University

NCT02547779

COMPLETED NA 5,114 participants

Perioperative Outcome Risk Assessment With Computer Learning Enhancement

Washington University School of Medicine

NCT05042804

COMPLETED NA 4,003 participants

Personalized Recommendations for Acute Kidney Injury (AKI) Care

Yale University

NCT04040296

COMPLETED 1,456 participants

International Registry of Acute Kidney Injury in Cirrhosis: The GLOBAL AKI Project

Azienda Ospedaliera di Padova

NCT05387811

COMPLETED 1,434 participants

Does the Presence of Preoperative Proteinuria Predict Postoperative Acute Kidney Injury in Obese Patients Undergoing Elective Laparoscopic Surgery?

NYU Langone Health

NCT02798042

Page 1 of 2 Next →

Phase Distribution

PhaseTrial count
Phase 1 6
Phase 2 16
Phase 3 4
Phase 4 2

Named interventions

Most-linked intervention names on Acute Kidney Injury records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Placebo Drug
7 trials
Physiologically-balanced isotonic crystalloid Other
2 trials
0.9% Saline Other
2 trials
Ketamine Drug
2 trials
Placebo Other
2 trials
AKI Risk Notification Other
1 trials
Calcifediol Drug
1 trials
Iohexol Device
1 trials

US sites by state

Facility locations filed on Acute Kidney Injury trials. A trial with sites in several states counts in each.

California 17 trials
Texas 15 trials
Massachusetts 15 trials
New York 14 trials
Alabama 14 trials
Ohio 13 trials
Michigan 13 trials
Florida 12 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Acute Kidney Injury page

75 registered trials, 33 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Acute Kidney Injury condition card totals 75 registered trials; most-linked intervention Placebo; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.